The Prescription She Never Picked Up

Fictional teaching case. The people and dialogue below are invented to illustrate a realistic communication dilemma. It is not a report about an identifiable patient, and the proposed approach is not individualized medical advice.

The medication list was accurate. The prescription had been sent. The patient had nodded when the clinician explained the plan.

And yet, six weeks later, she had never collected it.

Mara, 46, sat with her coat folded across her knees while Dr. Lee reviewed the follow-up notes. The previous visit had gone well, at least on paper: they had discussed why treatment was being recommended, the questions were answered, and the next appointment was booked.

Today, the clinician asked how the new medicine was going.

“Fine,” Mara said.

Then she hesitated.

“Actually, I didn't start it.”

There was a familiar pressure in the room. The appointment was running late. Dr. Lee wanted to know whether the recommendation had been misunderstood, whether a side effect was being feared, or whether something more serious had changed.

The tempting response was quick: You really need to take it as prescribed.

But that would answer a question nobody had yet asked.

The question behind “I didn't start it”

Dr. Lee looked away from the computer.

“Thank you for telling me. Would you help me understand what got in the way?”

Mara rubbed the edge of her sleeve.

“I went to the pharmacy. They told me what it would cost. I thought maybe I could come back after payday.”

She had not gone back.

The cost was not the only barrier. She was also paying for transport to care for her father, and missing an afternoon shift would mean losing wages. She had assumed the clinician would regard money as an excuse.

“I didn't want you to think I wasn't trying.”

Now the earlier agreement looked different. Mara had understood why the medicine was recommended. She had not agreed that she could obtain it.

A plan can make sense medically and still be impossible to follow in someone's actual life.

The turning point: from blame to practical information

Dr. Lee had a clinical reason to be concerned about the delayed treatment. That concern did not disappear when the cost became clear.

But the conversation changed direction.

“I am concerned you've been without the treatment we discussed. I'm also glad you told me. Cost is part of deciding what a workable plan looks like; it isn't a personal failing.”

Instead of asking Mara to promise again, they discussed the barriers separately.

• Clinical need: What problem was the medicine intended to address, and how urgent was starting treatment?
• Affordability: What would the pharmacy actually charge her, and could an appropriate alternative or assistance program be explored?
• Logistics: Could the next follow-up happen without another missed shift?
• Choice: Which options would Mara be comfortable considering, once the benefits, risks, and uncertainties were explained?

Dr. Lee did not guess at insurance coverage or substitute a medicine on the spot without checking. With Mara's agreement, the clinic involved the prescribing team and pharmacist to explore medically suitable, affordable possibilities and arranged a clear follow-up.

The solution was not a promise that every problem could be fixed immediately. It was a plan that made the barrier visible, took it seriously, and assigned responsibility for the next step.

What both people had missed

From the clinician's perspective, the initial conversation had covered the treatment's intended benefits and potential adverse effects.

From Mara's perspective, the cost question felt too private, too embarrassing, and too far outside what doctors normally wanted to discuss.

Neither intended for the plan to fail.

This is why “Do you agree?” may not be enough. Agreement with a clinical recommendation is not the same as the ability to act on it.

A more useful question might be:

“Before we settle on a plan, is there anything—cost, travel, time away from work, caring responsibilities, or something else—that could make it difficult to carry out?”

Asked routinely, and without making assumptions, this question gives people permission to discuss constraints before they become hidden reasons for delay.

Closing the loop without putting the patient on trial

At the end, Dr. Lee checked that the next steps were actually clear.

“I've given you a lot of information. To check I've explained this properly, could you tell me what you understand will happen after today?”

Mara explained whom the clinic would contact, when she expected to hear back, and what she should do if that contact did not happen or her condition changed. They clarified a detail she had misunderstood and recorded the agreed next steps.

The clinician had not tested her memory; the clinician had tested the clarity of the explanation.

Mara left with an unresolved medical concern, but no longer with a private problem she thought she had to hide.

Questions to consider

For clinicians

• Which part of the original encounter led you to assume the plan was feasible?
• How might you invite a cost conversation without making the patient disclose more than they wish?
• If you cannot change the cost or treatment immediately, what follow-up responsibility still belongs to the care team?

For patients and caregivers

• Is there a part of the proposed plan that is difficult to afford, arrange, understand, or accept?
• Do you know who to contact if a prescribed treatment cannot be obtained?
• Can you explain the next step in your own words, and does it fit your circumstances?

The takeaway

A treatment plan is not complete when it is explained. It has to be possible to carry out—or there needs to be a clear way to revisit it.

Clinical empathy does not replace appropriate treatment, solve structural poverty, or remove the clinician's duty to discuss risks. It helps make the real-world constraints visible early enough for shared planning.

For practical guidance, see Talking About the Cost of Care Without Shame and Closing the Loop: A Clear Plan Before the Visit Ends.

Evidence and further reading

• AHRQ, Talk About Costs — Health Literacy Universal Precautions Toolkit, Tool 23. Practical guidance on routinely raising cost, considering nonmedical expenses and arranging support.
• NICE, Shared Decision Making — NG197, recommendations 1.2.7–1.2.11 and 1.2.14–1.2.17. Guidance on discussing priorities and options, agreeing what happens next, and setting a time to review the plan.
• AHRQ, Use the Teach-Back Method — Health Literacy Universal Precautions Toolkit, Tool 5. Guidance on checking the clarity of explanations without testing or shaming the patient.

Evidence note: This is an illustrative educational scenario rather than evidence that one communication technique guarantees medication access or improved health outcomes. The references support the communication practices discussed, not the invented events of the story.